CCT8 and lung carcinoma: As shown in Figure 1C, CCT8 expression in two subtypes of lung cancer results in different clinical outcomes; higher expression of CCT8 is associated with poor survival in LUAD patients, while higher expression of CCT8 is good for LUSC patients.